Join
Live feed
·
PRReleasevia Quantisnow
Calithera Biosciences Inc. logo

Calithera Biosciences Announces Decision to Discontinue KEAPSAKE Clinical Trial

ByQuantisnow·Wall Street's wire, on your screen.
CALA· Calithera Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CALA (Calithera Biosciences Inc.) and more on Quantisnow.